| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721600 | Diabetes & Metabolism | 2018 | 9 Pages |
Abstract
While both SGLT-2i and DPP-4i can reduce A1c, SGLT-2i causes a more robust A1c reduction and more weight loss but with more genital infections. Higher doses of SGLT-2i showed more efficacy when compared to DPP-4i; however, this data should be interpreted cautiously given the limited number of trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
B.M. Mishriky, R.J. Tanenberg, K.A. Sewell, D.M. Cummings,